https://pepsreview.com/articles/oral-semaglutide-uptake-nears-injectable-levels-epic-study PepsReview en 2026-10-26 oral semaglutide, GLP-1, JAMA Network Open, Epic Cosmos, tirzepatide, weight management, obesity medication, telehealth https://pepsreview.com/articles/compounding-pharmacy-fails-revive-glp1-antitrust-case-lilly-novo PepsReview en 2026-10-26 GLP-1, antitrust, Eli Lilly, Novo Nordisk, compounding pharmacy, Strive Specialties, telehealth, enforcement https://pepsreview.com/articles/glp-1-demand-provider-oversight-safety-bottleneck PepsReview en 2026-10-25 GLP-1, semaglutide, tirzepatide, provider oversight, telehealth prescribing, compounded GLP-1, dosing errors, weight care https://pepsreview.com/articles/orforglipron-mace-data-achieve-4-cardiovascular-safety PepsReview en 2026-10-24 orforglipron, ACHIEVE-4, oral GLP-1, MACE, cardiovascular safety, insulin glargine, type 2 diabetes, Eli Lilly